BRD-K38687824

SynDRA canonical compound SYN0062589 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	APP
Mechanism of action	beta amyloid synthesis inhibitor

All known targets

APP

Mechanisms of action (all sources)

beta amyloid synthesis inhibitor

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

HDAC1
HDAC2
HDAC3
HDAC6
HDAC5

Cross-references

PubChem CID: 9882580
ChEMBL: CHEMBL4303349
LINCS BRD: BRD-K38687824

Synonyms

beta-amyloid-synthesis-inhibitor
N,N'-bis(3-hydroxyphenyl)pyridazine-3,6-diamine
RefChem:926409
RS0406
RS-0406
Phenol, 3,3'-(3,6-pyridazinediyldiimino)bis-
3,3'-(Pyridazine-3,6-diylbis(azanediyl))diphenol
3-({6-[(3-hydroxyphenyl)amino]pyridazin-3-yl}amino)phenol
3,3'-[Pyridazine-3,6-diylbis(azanediyl)]diphenol
3-[[6-(3-hydroxyanilino)pyridazin-3-yl]amino]phenol
orb1695391
orb3033063
SCHEMBL1317961
GLXC-10606
EX-A5203
AKOS040753839
PD063296
T34418
z530112-00-6
BRD-K38687824-001-01-7
BRD-K38687824-001-02-5

Look up BRD-K38687824 in the interactive SynDRA portal →